SAB BIOTHERAPEUTICS, INC. (SABS) Net margin 2020–2024
SAB BIOTHERAPEUTICS, INC. (SABS) net profit margin by fiscal year — reported net income divided by reported revenue.
-2579.0%FY2024 · since FY2020: 36.4% → -2579.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -2579.0% | -694.5 pp |
| FY2023 | -1884.5% | -1806.1 pp |
| FY2022 | -78.4% | -50.2 pp |
| FY2021 | -28.2% | -64.6 pp |
| FY2020 | 36.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice